ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,515Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 189

$795K Total Retail Price of All Prescriptions

Rank: 4 out of 189

641 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 641 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 641 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 14,230 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 676 614 1 2
FUROSEMIDE 657 635 2 10
OMEPRAZOLE 445 403 3 3
TRAZODONE HCL 434 397 4 16
AMLODIPINE BESYLATE 425 424 5 4
ATENOLOL 416 405 6 12
WARFARIN SODIUM 395 387 7 14
METOPROLOL TARTRATE 393 373 8 6
LISINOPRIL 379 341 9 1
LEVOTHYROXINE SODIUM 352 339 10 5
ATORVASTATIN CALCIUM 258 241 11 9
LOVASTATIN 235 235 12 21
GABAPENTIN 230 214 13 22
CITALOPRAM HBR 229 191 14 15
LOSARTAN POTASSIUM 220 204 15 20
SERTRALINE HCL 211 211 16 17
PRAVASTATIN SODIUM 206 191 17 13
DONEPEZIL HCL 203 203 18 27
HYDROCHLOROTHIAZIDE 201 173 19 8
SPIRIVA 200 191 20 33
POLYETHYLENE GLYCOL 3350 196 187 21 64
FELODIPINE ER 196 181 21 92
MIRTAZAPINE 164 163 23 45
METOPROLOL SUCCINATE 153 135 24 19
METFORMIN HCL 143 110 25 7
CLOPIDOGREL 137 126 26 48
ATENOLOL-CHLORTHALIDONE 133 133 27 87
NAMENDA 127 121 28 49
ALENDRONATE SODIUM 126 126 29 18
DIGOXIN 121 121 30 66
FOSINOPRIL SODIUM 120 120 31 146
LOSARTAN-HYDROCHLOROTHIAZIDE 120 113 31 43
CARVEDILOL 116 104 33 65
DIOVAN 109 108 34 51
FENOFIBRATE 108 101 35 36
DOXAZOSIN MESYLATE 105 105 36 63
TAMSULOSIN HCL 103 99 37 28
DILTIAZEM 24HR ER 102 70 38 68
TRICOR 97 79 39 106
JANUVIA 96 95 40 117
ALLOPURINOL 94 87 41 25
LANTUS 94 94 41 56
ADVAIR DISKUS 88 81 43 42
ENALAPRIL MALEATE 86 86 44 41
GLYBURIDE 82 69 R 45 60
GEMFIBROZIL 77 68 46 79
PLAVIX 75 74 47 74
PREDNISONE 75 72 47 38
BENAZEPRIL HCL 75 75 47 108
PAROXETINE HCL 75 75 47 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 73 51 23
CARBIDOPA-LEVODOPA 70 70 52 100
MELOXICAM 69 51 53 54
GLIPIZIDE ER 67 67 54 52
PROAIR HFA 65 55 55 35
PANTOPRAZOLE SODIUM 64 48 56 58
QUETIAPINE FUMARATE 64 64 56 78
TRAMADOL HCL 63 56 58 32
SYMBICORT 61 46 59 165
LIPITOR 61 52 59 57
GLIPIZIDE 59 59 61 39
DILTIAZEM 24HR CD 59 54 61 124
EVISTA 55 55 63 98
POTASSIUM CHLORIDE 54 54 64 61
CLOZAPINE 54 54 64 111
ISOSORBIDE MONONITRATE ER 50 49 66 85
RAMIPRIL 50 50 66 67
AMITRIPTYLINE HCL 50 37 R 66 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.